Article Details
Retrieved on: 2021-08-04 14:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche's heart attack drugs generated about $1.4 billion in sales last year, meaning a large market if Biogen or Lumosa get add-on therapies that can ...
Article found on: www.fiercebiotech.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here